Balrampur Chini ₹450cr Issue, PLA Capex ₹3,080cr Plan

Balrampur Chini Mills has approved a ₹450 crore preferential issue of equity shares, alongside a larger capital spending plan tied to its upcoming polylactic acid (PLA) project. The decisions were taken at the company’s board meeting held on April 23, 2026, and disclosed through filings and media reports.

Along with the equity raise, the board cleared a revision in the PLA project’s capital expenditure and approved a new lactogypsum processing plant in Uttar Pradesh. The company also sanctioned fund raising via listed, secured non-convertible debentures (NCDs) to add financing flexibility.

What the board approved on April 23, 2026

The board approved the issuance and allotment of up to 93,16,771 fully paid-up equity shares through a preferential issue. The issue price is set at ₹483 per share, including a premium of ₹482 per share, aggregating to ₹450 crore.

In the same meeting, the company increased the estimated capex for its 80,000 tonnes per annum PLA project and approved a separate lactogypsum processing plant at Kumbhi, Uttar Pradesh. The meeting reportedly commenced at 11:00 AM and concluded at 2:45 PM.

Preferential issue: size, price, and share count

The preferential issue involves 93.17 lakh shares (93,16,771 shares) at ₹483 each to raise ₹450 crore. The allotment spans 11 investor categories, including promoters, promoter group members, and non-promoter institutional investors.

The company said the proceeds will support its expanding capital expenditure plans and strategic initiatives, including the revised PLA project outlay. Shareholder approval is required, and the company has scheduled an Extraordinary General Meeting (EGM) to seek this approval.

Investor mix: promoters and institutions in the allotment

The disclosed allocation includes participation from promoters Vivek Saraogi and Sumedha Saraogi, promoter group entity Meenakshi Mercantiles Limited, and several institutional investors. Among institutions, the list includes TATA Small Cap Fund, Ikigai Emerging Equity Fund, 360 One Pipe Fund, multiple ICICI Prudential fund schemes, and Alchemy Alternative Investment Trust schemes.

The company also indicated that promoters would infuse ₹193 crore through the preferential issue. Within the disclosed non-promoter set, TATA Small Cap Fund is the single largest named subscriber by amount, followed by 360 One Pipe Fund.

Key investor allocations disclosed (₹ crore)

Note: Amounts are converted from rupee figures disclosed in the source to ₹ crore for consistency.

PLA project capex revised to ₹3,080 crore

Balrampur Chini revised the estimated capital outlay for its 80,000 tonnes per annum PLA project from ₹2,850 crore to ₹3,080 crore. The revision implies a ₹230 crore increase over the earlier estimate.

The company attributed the increase to higher prices of key construction materials, global supply chain disruptions, and changes in engineering and design that emerged during the modelling review. It also said the revised capex, including cost escalations, will be funded through a mix of equity (including the preferential issue), debt, and internal accruals.

New lactogypsum processing plant at Kumbhi, Uttar Pradesh

The board approved setting up a lactogypsum processing plant at Kumbhi, Uttar Pradesh, with an estimated investment of up to ₹160 crore. The plant is intended to process lactogypsum generated as a by-product from the PLA manufacturing operations.

The facility is planned with an installed capacity of about 76 lakh gypsum boards per annum. Commercial production is expected by December 2027, as per the disclosed plan.

Additional fund raising: NCDs up to ₹200 crore

Beyond the equity issuance, the board approved issuance of listed, secured non-convertible debentures aggregating up to ₹200 crore on a private placement basis. The NCDs may be issued in one or more tranches.

The company indicated that specific terms such as tenure, coupon rate, and security details will be disclosed at the time of each allotment.

Dates investors will track: EGM and conference call

An Extraordinary General Meeting is scheduled for May 20, 2026, to seek shareholder approval for the preferential issue and other board-approved initiatives.

The company also scheduled a conference call for investors and analysts on April 28, 2026, at 12:00 Noon IST to discuss updates on the PLA project and the capital raising plan.

Snapshot: operational scale and recent stock performance

Balrampur Chini Mills operates as one of India’s largest integrated sugar companies. It has ten sugar factories in Uttar Pradesh with an aggregate sugarcane crushing capacity of 80,000 tonnes per day (TCD). It also has distillery operations of 1,050 kilo litres per day (KLPD) and cogeneration capacity of 175.7 MW.

On the market side, the stock was indicated at ₹540.30, down ₹1.25 (0.23%). Historical returns shared in the same context showed: 1 day -0.23%, 5 days +11.32%, 1 month +11.20%, 6 months +15.28%, 1 year -8.67%, and 5 years +101.87%.

Key approvals summary table

Why the announcements matter

The announcements combine equity funding, incremental debt capacity, and a revised capex roadmap for a large non-sugar project. The PLA capex hike also clarifies that the project’s cost structure has changed, with the company pointing to materials inflation, supply chain disruptions, and design modifications.

The addition of a lactogypsum plant links the PLA investment to a downstream by-product monetisation plan. Separately, the preferential issue structure indicates participation across promoters, promoter group, and a set of institutional investors, with the final allotment subject to shareholder approval at the scheduled EGM.

What to watch next

The next formal milestones are the April 28 investor call and the May 20 EGM. Investors will also watch for subsequent disclosures on the NCD tranches, since terms are expected to be announced at the time of each allotment.

For the project side, the company’s stated timelines include commercial production for the gypsum-board facility by December 2027, while the PLA project’s funding plan relies on the equity raise, debt, and internal accruals as outlined in the approvals.